Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th...